The authors have no conflicts of interest to disclose Biomarker studies in patients treated with PD1 checkpoint inhibitors should include assays combining PD-L1 expression and TIL characterization to assess whether the combination is more predictive of response to therapy than PD-L1 alone.
Introduction
The recent demonstration that blockade of PD-1/PD-L1 checkpoint pathway is effective for several cancers including melanoma and non small cell lung cancer have The prognostic role of PD-L1 expression in tobacco-induced HNSCC has not been previously determined. Tobacco-induced HNSCC bear a large number of mutations which render them immunogenic.
Given the promising results of PD-1/PD-L1 inhibitors in clinical trials for R/M
HNSCC, we used a well annotated cohort of 260 laryngeal cancers (9) to characterize PD-L1 protein expression and TIL level in association with clinical outcome. We also evaluated PD-L1 mRNA levels in the above mentioned formalin fixed paraffin embedded (FFPE) cohort as well as in a second independent well-annotated cohort of 89 fresh frozen specimens of paired tumors and normal adjacent tissues.
Materials and Methods

Patient cohorts
The study was conducted retrospectively in a cohort of 260 patients (cohort I) with primary SCC of the larynx (Table 1) Patients were endoscopically evaluated at regular monthly visits for the first year after surgery and every two months thereafter and staged with CT of the neck and chest every six months for the first two years after surgery and yearly thereafter or sooner if clinically indicated. Other diagnostic or staging procedures were performed upon clinical indications or symptom alert.
Histological evaluation of tumor-infiltrating lymphocytes (TILs)
Evaluation of TILs was performed in hematoxylin-eosin (H/E) stained whole FFPE sections, which were examined at X100 and X400 magnification fields using a conventional light microscope by a certified pathologist (K.C.) to ensure homogeneous assessment. Currently, different methods have been practiced for assessing tumor immune response with respect to lymphocytic infiltrations on FFPE sections, including morphological evaluation of TILs (11) (12) (13) , immunophenotyping (14, 15) , immunoscoring with CD3/CD8 (16) . Herein, we preferred to apply only the morphological assessment as a first pragmatic and cost-effective approach of TILs estimating the ratio of the area occupied by mononuclear cell infiltrates to the entire stromal area (% TILs = area occupied by mononuclear cells in tumor stroma / total stromal area) (13) . Based on the same recommendations, intra-tumoral lymphocytes, i.e., those in immediate proximity to neoplastic cells within tumor nests, should be avoided. However, due to variations in tumor patterns of growth, such single lymphocytes occurring in small numbers were occasionally indistinguishable from stromal ones; nevertheless, these were scarce and not expected to have interfered with the overall TILs density. Sections from all available blocks (>1 block available in 53 cases) from the same tumor were evaluated and the average density was calculated, in order to adjust for TILs heterogeneity in each tumor.
Tissue Microarray Construction
Haematoxylin-eosin (H&E) stained slides from tissue blocks had been reviewed for adequacy of tumor tissue and estimation of the percentage of tumor cells in each case (9) . Two hundred sixty formalin-fixed paraffin-embedded tissue blocks (cohort I) were histologically evaluated for tumor type, marked for tissue microarray (TMA) construction and, where necessary, for manual macrodissection. Low-density TMAs (approx. 30 tumors per TMA block) were constructed with two tissue cylinders of 1.5 mm in diameter per tumor. The latter was performed on 8um unstained deparaffinized sections in order to increase tumor cell content in the subsequently extracted molecular templates, which contained >50% tumor cells in 64.2% of the cases and 30-50% in the remaining ones. The flow chart of the study including the corresponding sample numbers is presented in Figure 1A (REMARK diagram). 
Quantitative Immunohistochemistry
For automated quantitative protein analysis we used TMA sections, because the method operates more accurately on such histologic material (17) . TMA sections were deparaffinized and stained as previously described using a non-commercial mouse monoclonal primary antibody to PD-L1 (clone 5H1, generated by Dr. Lieping Chen) which had been validated in previous studies using quantitative immunohistochemistry on neoplastic tissue and tumor cell lines (18, 19) . For validation of PD-L1 antibody, a custom designed PD-L1 control TMA was used. This 
Automated image acquisition and quantitative protein analysis
Automated image acquisition and analysis using automated in situ quantitative measurement of protein analysis (AQUA) has been described previously (17) . In brief, monochromatic, high-resolution (1,024 × 1,024 pixel; 0.5μm) images were obtained of each histospot. We distinguished areas of tumor from stromal elements by creating a mask from the cytokeratin signal. 4',6-Diamidino-2-phenylindole signal was used to identify nuclei, and the cytokeratin signal was used to define cytoplasm.
Overlapping pixels (to a 99% confidence interval) were excluded from both compartments. The signal (AQUA score) was scored on a normalized scale of 0 to 255 expressed as pixel intensity divided by the target area. AQUA scores for each subcellular compartment (nuclear and cytoplasmic) as well as the tumor mask were recorded. AQUA scores for duplicate tissue cores were averaged to obtain a mean score for each tumor. To verify antibody specificity, we used control tissue microarrays containing placenta and tonsil tissue (known to be positive for PD-L1) and pellets from MEL-624 cell lines, positive or negative for PD-L1 and NSCLC cases with previously measured levels of PD-L1 expression, as previously described (18, 20) . Relative quantification of PDL1 mRNA levels was performed by the 2 -ΔΔC T method, using the average C T, as calculated from the duplicate reactions for each tested sample. GAPDH endogenous reference gene was used for normalization purposes and the CAL-33 cell line as our assay calibrator. Exclusion criteria for sample relative quantification analysis were GAPDH average C T values higher than 33 for each duplicate.
RNA extraction and PD-L1 expression quantification by qRT-PCR
on
Statistical analysis
For the analysis of PD-L1 expression levels between the different TILs groups of the patients according to Schalper et al. (21) , the non-parametric Jonckheere- The X-tile algorithm (22) was used for the adoption of optimal cut-off value of PD-L1 protein expression, which was equal to the 58 th percentile of PD-L1 AQUA levels, while for PD-L1 mRNA levels the median expression of the tumor samples was used as cut-off for each cohort. Kaplan-Meier survival curves using log-rank test
and Cox proportional regression analysis were used in order to assess the prognostic significance of TILs, PD-L1 expression for the disease-free survival (DFS) and overall survival (OS) of the patients following treatment.
Results
Baseline clinical and experimental data
The cohort I of 260 tumors of primary laryngeal SCC was evaluated for stromal TILs as well as PD-L1 protein and mRNA levels. The clinicopathological characteristics of the patients are presented in Table 1 . Management consisted of surgical resection of the tumor by means of total laryngectomy (86.2%) or by more conservative procedures (13.8%). A neck dissection was performed in 28.5% of cases, while post-operative external beam radiotherapy was administered in 32.7%.
Median patient age was 63.0 years. The majority of the patients were males (95.8%), current or ex smokers (95.0%) and alcohol consumers (74.6%). As ex smokers were characterized those individuals who discontinued tobacco at least 5 years before the diagnosis of larynx cancer. Ingestion of 15-18 g of alcohol 2-3 times a week was defined as mild alcohol consumption. As moderate and heavy alcohol use we defined the daily uptake of 15-18 g and 30 or more g of alcohol, respectively. As shown in Table 1 , diagnostic work-up led to diagnosis of laryngeal SCC predominantly supraglottic or glottic (90% of cases), mostly stage T3-4 (79.6% of cases) and more often node-negative at clinical/radiological examination (84.6%). 
For cohort II, PD-L1 mRNA levels were quantified in 89 tumors and 73 normal adjacent tissue specimens ( Figure 1A) . The demographics and treatment characteristics of the second cohort are included in Table 1 .
Higher TILs is strongly correlated with increased PD-L1 protein levels
According to TILs percentage, the patients (N=252) were classified to low Figure 1D ). PD-L1 mRNA levels were significantly correlated with PD-L1 protein levels (r s =0.403; p<0.001; Figure 1E ), but not with TILs in Spearman analysis (r s =0.130; p=0.125).
Analysis of TILs and PD-L1 expression with clinicopathological features
The analysis of PD-L1 mRNA levels in tumor specimens and normal adjacent Table 1 (categorical variable) . Decreased TILs density were observed in patients with higher alcohol consumption (p=0.043), while no statistically significant correlation was observed with T stage, grade, nodal stage or smoking behavior. Concerning PD-L1, lower protein expression was noted in patients with higher smoking-index (p=0.022), while stronger staining was observed in nodepositive patients (p=0.018). Finally, the study of PD-L1 mRNA levels in FFPE and fresh frozen specimens did not reveal any statistically significant correlation with patients' and disease features.
TILs and PD-L1 protein expression represent independent predictors of laryngeal SCC patients' disease-free and overall survival
Kaplan-Meier and Cox proportional regression analysis performed for the evaluation of TILs and PD-L1 value to predict patients' disease-free survival (DFS) and overall survival (OS) following treatment.
The level of stromal TILs was strongly associated with superior survival outcome of the patients. Kaplan-Meier curves (Figure 2A ) highlighted the poor DFS (p=0.009) of the patients with low TILs percentage compared to those with high TILs.
Similarly, the patients with low stromal TILs demonstrated significantly worse OS (p=0.015) compared to the high TILs group ( Figure 2B ). The favorable outcome of the high TILs cohort was also supported by Cox regression analysis (Table 2 ).
Univariate analysis (Table 2 and Figures 2C and 2D) Figure 2E ) and univariate Cox regression analysis (HR: 0.591; 95% CI: 0.351-0.996; p=0.048; Table   2 and Figure 2C ) for the patients with higher PD-L1 expression compared to those with downregulated levels. Moreover, Kaplan-Meier analysis (p=0.059; Figure 2F) and univariate Cox regression (HR: 0.635; 95% CI: 0.393-1.024; p=0.062; Table 2 and Figure 2D ) highlighted the trend of the patients overexpressing PD-L1 for superior OS outcome.
Multivariate Cox regression models, adjusted for tumor stage, grade, nodal status, alcohol consumption, smoking behavior, age and gender, were used for the evaluation of the independent prognostic value of TILs and PD-L1 (Table 2) In our study, we did not find a correlation between PD-L1 mRNA expression and outcome in two independent cohorts of HNSCC although a strong association between PD-L1 mRNA and PD-L1 protein levels was noted. The difference might be explained, at least in part, by the distinct properties and independent information provided by PD-L1 protein and mRNA molecules, as reported (33) . Methodological differences might also account for the apparent inconsistency.
Our analysis has a number of limitations. One limitation is that it includes retrospectively collected cases. A second limitation is that the use of TMAs may underestimate or overestimate the PD-L1 protein levels due to intratumoral heterogeneity of expression. Although our results support the value of measuring PD- 
